Curexo
Curexo Inc. (KOSDAQ: 060280) is a South Korea-based medical robotics company that designs and sells fully automated orthopedic surgical robots (CUVIS-joint, CUVIS-spine) and the MorningWalk gait rehabilitation robot to hospitals and medical institutions across Asia, Europe, the Americas, the Middle East, and Africa.
- Company typePublic
- Founded2017
- HeadquartersSeoul, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Curexo does
Curexo Inc. (ticker: 060280 KOSDAQ) is a South Korea-based medical robotics company that designs, manufactures, and sells surgical and rehabilitation robot systems to hospitals and medical institutions. The company was established in 2017 when it acquired Hyundai Heavy Industries' medical business division and built core technology on top of assets acquired from U.S.-based ISS, positioning itself as Korea's only pure-play medical robotics company. Its product portfolio consists of CUVIS-joint (a fully automated orthopedic surgery robot for knee and now hip arthroplasty with CT-based 3D planning and autonomous bone cutting), CUVIS-spine (a navigation-guided spinal surgery robot for pedicle screw placement), and the MorningWalk / MorningWalk S200 end-effector gait rehabilitation robot. The systems incorporate proprietary AI-based surgical planning, real-time optical tracking, and open-platform compatibility with implants from multiple manufacturers.
Curexo generates revenue primarily through one-time capital equipment sales to hospitals, supplemented by recurring revenue from surgical instruments and consumables tied to the installed base, plus installation, training, and after-sales service contracts. Its go-to-market combines direct enterprise field sales (especially in Korea and key international markets) with regional distribution partners, including Permedica for Italy and Morocco, ARTIMEDICA for Mexico, Droguepar S.A. for Paraguay, M&M Brazil for Latin America, OrthoHouse for Egypt, Harmonic Bionics and AEGIS Spine in the United States, CG Bio for Korea spine distribution, and Fourier Intelligence for global MorningWalk distribution across 50+ countries. Demand generation relies heavily on major orthopedic and rehabilitation conferences (AAOS, KIMES, JARM, NASS, ITC) and live surgery demonstrations at partner hospitals.
In 2025, Curexo shipped 88 medical robots (73 CUVIS-joint, 8 MorningWalk, 4 In Motion, 3 CUVIS-spine), up 41.9% from 62 units in 2022, and reported revenue growth of approximately 37% in 2025 driven by approvals and unit expansion. Its regulatory footprint covers Korean MFDS, US FDA, European CE MDR, Japanese PMDA, Indian CDSCO, and Mexican COFEPRIS, with 2026 marking the entry into the U.S. and broader European markets. Curexo is publicly listed on KOSDAQ with no disclosed venture or private equity funding rounds and no parent company.
Curexo firmographics
Firmographics- Name
- Curexo
- Legal name
- CUREXO Inc.
- Website
- https://curexo.com
- Company type
- Public
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Curexo Inc. (KOSDAQ: 060280) is a South Korea-based medical robotics company that designs and sells fully automated orthopedic surgical robots (CUVIS-joint, CUVIS-spine) and the MorningWalk gait rehabilitation robot to hospitals and medical institutions across Asia, Europe, the Americas, the Middle East, and Africa.
- Ownership category
- akta.pro rank
Curexo industry classification
Industry- Product category
- Medical Robotics Systems
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Healthcare & Assistive Robotics (HDAAAIAC)
Keywords
Where Curexo is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices3 records
Markets served
Curexo business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Medical Robot Hardware Sales: Sale of surgical robots (CUVIS-joint, CUVIS-spine) and rehabilitation robots (Morning Walk) as capital equipment to hospitals and medical institutions. The company has supplied 88 units in 2023 and targets 100+ units annually.
- Consumables and Surgical Instruments: Sales of surgical instruments and consumables used during robotic surgeries, providing recurring revenue from installed base
- Service and Technical Support: Installation, training, and after-sales service (A/S) provided through technical support teams, including both domestic and international clinical/technical support
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | CUVIS-joint (Artificial Joint Surgery Robot) - enterprise pricing |
| One time/ perpetual license | Multi-year contract | CUVIS-spine (Spine Surgery Robot) - enterprise pricing |
| One time/ perpetual license | Multi-year contract | Morning Walk (Gait Rehabilitation Robot) - enterprise pricing |
Go-to-market motion3 records
Distribution channels8 records
Marketing channels8 records
Curexo product offering
Product offeringCore offering
Curexo designs, manufactures, and sells medical robotics systems for orthopedic surgery, spine surgery, and lower-limb rehabilitation. Its product portfolio includes the CUVIS-joint fully automated joint replacement surgery robot (knee and hip), the CUVIS-spine spinal surgery robot for pedicle screw guidance, and the MorningWalk end-effector gait rehabilitation robot. The company supplies these robots as capital equipment to hospitals and medical institutions globally, supported by installation, training, and after-sales services along with recurring surgical instrument and consumable sales.
Product overview
Curexo is a medical robotics company specializing in surgical and rehabilitation robots. The product portfolio consists of two surgical robot systems and one rehabilitation robot: CUVIS-joint (fully automated joint replacement surgery robot), CUVIS-spine (spinal surgery robot with pedicle screw guidance), and MorningWalk/MorningWalk S200 (end-effector gait rehabilitation robot). CUVIS-joint operates as an open-platform system compatible with multiple implant manufacturers, while CUVIS-spine and MorningWalk serve distinct clinical applications in spine surgery and rehabilitation, respectively. The company offers products covering the full patient care continuum from surgical intervention to recovery.
Differentiator
Problem solved
Functional benefit
Brands
- CUVIS-joint: Fully automated robotic system for joint replacement surgery (knee and hip arthroplasty) with AI-based surgical planning and precision bone cutting.
- CUVIS-spine
- MorningWalk
Products and services
- CUVIS-joint A fully automated robotic system for joint replacement surgery that analyzes patient CT scans in 3D to establish optimized surgical plans and uses a multi-joint robotic arm to precisely cut bone during surgery. Features an open-platform architecture compatible with implants from multiple manufacturers and supports patient-specific procedures. Used by orthopedic surgeons and hospitals performing total knee, unicompartmental knee, and total hip arthroplasty.
- CUVIS-spine A spinal surgery robot system that provides precise guidance for pedicle screw insertion through preoperative image-based planning and real-time patient position tracking. Combines robotic accuracy with conventional surgical approaches to reduce surgical variability and radiation exposure. Used by neurosurgical and orthopedic spine surgery departments in hospitals.
- MorningWalk A footplate-based end-effector gait rehabilitation robot designed for patients with lower-limb paralysis or gait impairments, including stroke, spinal cord injury, Parkinson's disease, and post-surgery recovery. Offers shorter setup times and varied gait training patterns compared to exoskeleton systems, and includes propulsion feedback training for active gait training. Designed for both pediatric and adult populations. Used by rehabilitation hospitals and physical therapy centers.
Quantifiable outcome
- CUVIS-joint cumulative surgeries: 43,000+ cases across 9+ countries
- +4 more outcomes
Companies that use Curexo
Customer profileNamed customers12 records
Segments4 records
Ideal customer profiles3 records
Curexo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature8 records
Curexo partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered core and minor.
- Droguepar S.A.coreParaguayan medical device company partnered for CUVIS-joint supply agreement, marking Curexo's entry into Paraguay market and expansion of Latin American footprint.
- ARTIMEDICAcoreMexican medical device company collaborating with Curexo for local sales and marketing of CUVIS-spine following COFEPRIS regulatory approval.
- Permedica S.p.A.coreItalian orthopedic implant company (founded 1986) serves as distribution partner for CUVIS-joint in Italy and Morocco. Joint surgery demonstration at FM6SS Morocco showcased synergy between Curexo's bone cutting and Permedica's implants. Open platform strategy enables collaboration across implant manufacturers.
- Korean Trade-Investment Promotion Agency (KOTRA)coreKOTRA organized Korea-India Business Partnership Forum where Curexo participated to expand Indian market network. Forum held during bilateral summit schedule in New Delhi.
- M&M BrazilminorLocal partner for participation in CBCJ 2026 (Brazilian Knee Surgery Congress) in São Paulo, showcasing CUVIS-joint at booth #12.
- CG Bio (시지바이오)coreKorean bio-regenerative medicine company signed exclusive domestic distribution agreement for CUVIS-spine. Partnership aims to expand in domestic and international spine surgery markets through robot-navigation-based platform.
- SPG (Sangsang Precision Group)coreSPG signed MOU to supply precision actuators for Curexo's medical robots. Partnership aims to localize core components and enhance global competitiveness through custom actuator design, technical exchanges, and joint marketing activities.
- OrthoHousecoreEgyptian partner company participating with Curexo at ITC 2026 (International Trauma Congress) in Dubai for MENA market expansion.
- Indian SubsidiarycoreCurexo established Indian subsidiary for direct market presence and local network expansion in India's high-growth medical robotics market.
- Harmonic BionicsminorUS-based Harmonic Bionics partnered with Curexo to distribute the Morning Walk S200 gait rehabilitation system in the walking assist devices market.
- Think Surgical Inc. (TSI)minorPartnership for AAOS 2024 exhibition where CUVIS-joint (US product name: TMAX) was showcased to US market.
- Neuromeka (뉴로메카)coreKorean robot automation platform company partnered for supply of robot manipulators. Strategic partnership led to purchase agreement for 200 robot manipulators including trial production of CUVIS-joint robot arm prototypes.
- AEGIS Spine Inc.minorUS spine implant company distributing CUVIS-spine in United States market for spine surgery procedures.
- Fourier IntelligencecoreStrategic global partnership for distribution of Morning Walk gait rehabilitation robot. Fourier's network spans 50+ countries including Singapore, Malaysia, Thailand, UK, Australia. Also exploring joint technology development for rehabilitation robotics.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Curexo competitors and assessment
Company assessmentBroad incumbents
- Stryker (Mako): Stryker's Mako robotic-arm-assisted surgery system is the dominant robotic joint replacement platform globally, with thousands of installations and the largest US installed base. Directly comparable to CUVIS-joint in TKA/THA, though Stryker operates at vastly larger scale and with proprietary closed-platform integration.
- Intuitive Surgical (da Vinci): Intuitive Surgical's da Vinci is the dominant general-surgery robotic platform globally with a vast installed base. While da Vinci does not directly compete in orthopedics, it defines the hospital robotic-surgery procurement landscape that CUVIS-joint and CUVIS-spine compete within.
Direct peers
- Renishaw (Neuromate / neurosurgical robotics): Renishaw's neuromate robotic system targets stereotactic neurosurgery, sharing technological overlap with CUVIS-spine's image-guided pedicle screw placement. Both are precision-guided surgical robotic platforms competing for hospital surgical departments.
- Globus Medical (ExcelsiusGPS): Globus Medical's ExcelsiusGPS is a leading robotic spine surgery platform with strong US hospital penetration. Directly comparable to CUVIS-spine, with similar navigation-and-arm integration approach; Globus pairs robotics with its own spine implant portfolio.
- Medtronic (Mazor / Hugo): Medtronic's Mazor robotic guidance system is a market leader in spine robotics, directly competing with Curexo's CUVIS-spine for hospital spine surgery accounts. Medtronic also operates Hugo for general surgery, providing scale and breadth Curexo lacks.
- Zimmer Biomet (ROSA): Zimmer Biomet's ROSA robotic system spans knee, hip, and spine indications, directly overlapping with Curexo's CUVIS-joint and CUVIS-spine portfolio. As one of the 'big five' orthopedic players, Zimmer Biomet competes on bundled implants and an established sales network.
- Smith+Nephew (CORI): Smith+Nephew's CORI handheld robotic system targets robotic-assisted knee surgery with a compact, image-free design. Directly comparable to CUVIS-joint in surgical indication and target customer segment, though Smith+Nephew has a much broader orthopedic portfolio and established global salesforce.
- THINK Surgical: THINK Surgical develops open-platform robotic systems for orthopedic surgery — architecturally aligned with Curexo's implant-agnostic CUVIS-joint strategy. Curexo has an existing partnership with TSI for AAOS exhibitions, and the two are direct competitors in open-platform orthopedic robotics.
- Hocoma (rehabilitation robotics): Hocoma (a DIH Medical company) is a leading developer of robotic and sensor-based rehabilitation devices including gait-training systems. Directly comparable to Curexo's Morning Walk in end-effector gait rehabilitation for stroke and orthopedic patients.
Emerging players
- Fourier Intelligence: Fourier Intelligence is a Chinese rehabilitation robotics company and Curexo's exclusive global distribution partner for Morning Walk. Overlapping product portfolio in gait-rehabilitation robotics makes it both a channel partner and a direct competitor in select end markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Curexo social profiles
Digital presenceCurexo compliance and trust
Trust signalCompliance3 records
Curexo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Curexo leadership team
Management profileNumber of profiles
Profiles2 records
Curexo funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Curexo M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Curexo
What does Curexo do?
Curexo designs, manufactures, and sells medical robotics systems for orthopedic surgery, spine surgery, and lower-limb rehabilitation. Its product portfolio includes the CUVIS-joint fully automated joint replacement surgery robot (knee and hip), the CUVIS-spine spinal surgery robot for pedicle screw guidance, and the MorningWalk end-effector gait rehabilitation robot. The company supplies these robots as capital equipment to hospitals and medical institutions globally, supported by installation, training, and after-sales services along with recurring surgical instrument and consumable sales.
Is Curexo a public or private company?
Curexo is a public company. It is classified as public and is currently operating.
When was Curexo founded?
Curexo was founded in 2017. It employs 11 to 50 people.
Where is Curexo based?
Curexo is headquartered in Seoul, South Korea, in the Asia region.
How does Curexo make money?
Three revenue lines are on record. Medical Robot Hardware Sales are the primary driver. The others are consumables and Surgical Instruments and service and Technical Support.
Who are Curexo's main competitors?
Broad incumbents on record are Stryker (Mako) and Intuitive Surgical (da Vinci). Direct peers are Renishaw (Neuromate / neurosurgical robotics), Globus Medical (ExcelsiusGPS), Medtronic (Mazor / Hugo), Zimmer Biomet (ROSA), Smith+Nephew (CORI), THINK Surgical and Hocoma (rehabilitation robotics). Fourier Intelligence is listed as an emerging player.
Does Curexo have an API?
No public API is recorded for Curexo.
What industry is Curexo in?
Curexo's product category is Medical Robotics Systems. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3841.